NLRP3 and gout: These results demonstrate that dapansutrile effectively alleviates target joint pain and local/systemic inflammation during acute gout flares, highlighting its potential as a novel NLRP3 inflammasome-targeted inhibitor for treating gout attacks and other NLRP3-mediated diseases.